NU 621 Unit 4 case study analysis example

Pain, Pallor, and a Falling Oxygen Saturation: A Case Study Analysis of Sickle Cell Vaso-Occlusion

Student Name

Department of Nursing, Herzing University

NU 621: Advanced Pathophysiology

Instructor Name

February 9, 2026

Pain, Pallor, and a Falling Oxygen Saturation: A Case Study Analysis of Sickle Cell Vaso-Occlusion

The Case and the Question

T. W., a composite 24-year-old man with sickle cell anemia (hemoglobin SS), comes to the emergency department with two days of severe aching pain in his lower back and both thighs after a week of working outdoors in hot weather with little fluid intake. He is pale and uncomfortable. Temperature 99.9 F, heart rate 112, respiratory rate 20, blood pressure 118/64, oxygen saturation 95% on room air on arrival and 92% six hours later. Auscultation finds a soft systolic flow murmur along the left edge of the sternum. Hemoglobin is 7.1 g/dL, below his baseline of 8.4 g/dL. The reticulocyte count is elevated, lactate dehydrogenase is high, and total bilirubin is 3.2 mg/dL, mostly unconjugated. His white cell count is 15,800 per microliter. Six hours after admission he describes a new sharp pain in the right lower chest that catches each time he inhales.

The question this analysis answers is: how does a single abnormal hemoglobin molecule produce pain in the bones, a falling hemoglobin, jaundice-range bilirubin, a fast heart with a murmur, and, later, a falling oxygen saturation with chest pain in the same patient? The analysis stays with mechanism and trajectory; it does not select treatment.

Working Backward: From the Pain to the Molecule

The deep, aching pain in his back and thighs is ischemic pain from bone marrow. Marrow sits inside rigid bone, and when its small vessels are blocked, the tissue becomes ischemic and, if the block persists, infarcts, producing pain that is severe and poorly localized. The question is what blocked the vessels.

The block is formed by red cells that have lost their ability to deform. In hemoglobin S, a single amino acid substitution, valine for glutamic acid at position 6 of the beta-globin chain, creates a hydrophobic patch on the molecule's surface. When hemoglobin S gives up its oxygen, the deoxygenated molecules bind to one another through this patch and polymerize into long, stiff fibers inside the red cell (Rees et al., 2010). The polymer distorts the cell into the sickle shape and makes it rigid. Rigid cells cannot squeeze through capillaries and small venules, and they lodge there.

The rate of polymerization depends steeply on the concentration of hemoglobin S inside the cell. Dehydration of the red cell raises that concentration and shortens the time before polymerization begins, so that more cells sickle while still in the microcirculation rather than after they have passed through it (Rees et al., 2010). The week of outdoor work in heat with little fluid is therefore not background; it is the plausible trigger that tipped his red cells toward polymerization.

Working Forward: How the Response Generated the Rest

Vaso-occlusion is not simply a traffic jam of rigid cells. Sickle cells are abnormally adhesive to the endothelium, and they activate it, increasing the expression of adhesion molecules. Leukocytes, particularly neutrophils, adhere to the activated endothelium and to sickle cells, forming larger aggregates that slow flow further (Kato et al., 2018). Slower flow means more time for deoxygenation, which means more polymerization, which means more sickling. The response to the first occlusion therefore feeds the next one. His raised white cell count is part of this picture: activated neutrophils are not only a marker of stress but active participants in the occlusion.

The falling hemoglobin, high lactate dehydrogenase, unconjugated bilirubin, and high reticulocyte count come from a second consequence of the same polymer. Repeated cycles of sickling damage the red cell membrane, and the cells are destroyed early, both in the spleen and liver and directly in the circulation. This hemolysis releases lactate dehydrogenase and hemoglobin, whose breakdown produces the unconjugated bilirubin. The marrow responds by increasing red cell production, which is the high reticulocyte count. Free hemoglobin released into the plasma also scavenges nitric oxide, reducing its vasodilating effect and further promoting vascular constriction and endothelial activation (Kato et al., 2018).

The tachycardia and the soft systolic murmur are compensation for anemia. With less hemoglobin to carry oxygen, the body maintains oxygen delivery by increasing cardiac output, mainly through heart rate and stroke volume. Faster flow across normal valves creates turbulence heard as a flow murmur. The compensation protects the tissues for now, but it raises the heart's own oxygen demand at a time when oxygen carrying capacity is reduced.

The Findings the First Chain Does Not Explain

The first chain explains the bone pain, the hemolysis, and the cardiac compensation. It does not fully explain the new pleuritic chest pain and the fall in oxygen saturation from 95% to 92% six hours after admission. A second process has to be named. The most plausible is the acute chest syndrome, in which vaso-occlusion occurs in the pulmonary circulation, frequently alongside infection or fat embolism from infarcted marrow (Vichinsky et al., 2000). In the large multicenter study by Vichinsky et al. (2000), acute chest syndrome often developed after hospital admission for a painful crisis, which matches the timing in this case.

The mechanism of acute chest syndrome is a dangerous loop. Occluded pulmonary vessels and inflamed lung tissue reduce ventilation in some areas, so blood passing those areas leaves the lungs less oxygenated. Lower oxygen tension in the pulmonary venous blood and beyond increases deoxygenation of hemoglobin S, which increases polymerization and sickling, which causes more occlusion. Splinting from pleuritic pain reduces ventilation further. A competing explanation is simple atelectasis from shallow breathing due to pain; the finding that argues against atelectasis alone is the low-grade fever with a rising white count, although both could coexist.

Trajectory if Nothing Interrupts the Chain

If the loops described above continue, the mechanism predicts a clear order of worsening. Oxygen saturation falls further as more pulmonary vessels occlude. Hemoglobin falls further as sickling and hemolysis continue and as sequestration of red cells in the lungs increases. The heart, already working hard to compensate for anemia, faces rising pulmonary vascular resistance and can begin to fail on the right side. Marrow infarction releases fat and debris that can embolize to the lungs. The trajectory runs from a painful crisis to respiratory failure over hours to days, which is why the fall from 95% to 92% is the most important number in the case, even though the pain is the most prominent complaint.

References

Kato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., Smith, W. R., Panepinto, J. A., Weatherall, D. J., Costa, F. F., & Vichinsky, E. P. (2018). Sickle cell disease. Nature Reviews Disease Primers, 4, Article 18010. https://doi.org/10.1038/nrdp.2018.10

Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010). Sickle-cell disease. The Lancet, 376(9757), 2018-2031. https://doi.org/10.1016/S0140-6736(10)61029-X

Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C., Manci, E. A., & National Acute Chest Syndrome Study Group. (2000). Causes and outcomes of the acute chest syndrome in sickle cell disease. New England Journal of Medicine, 342(25), 1855-1865. https://doi.org/10.1056/NEJM200006223422502